Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $0.0035 USD
Change Today 0.00 / 0.00%
Volume 0.0
As of 8:10 PM 11/3/15 All times are local (Market data is delayed by at least 15 minutes).
text size: T | T
Back to Snapshot
Company Description

Contact Info

143 Gardner Road

Brookline, MA 02445

United States

Phone: 617-566-5228


Xeno Transplants Corp. operates as a bio-technology research and development company. The company, through a license agreement with Massachusetts General Hospital, intends to develop, manufacture, distribute, and use products and processes for public use with regard to xenotransplantation. Xenotransplantation is intended to address the problems arising from the limited supply of available human cells, tissues, and organs for transplantation by developing technologies to permit the transplantation of cells, tissues, and organs from other species, such as swine, into humans. Transplant Programs The company is also evaluating other GalT-KO xenotransplant product development opportunities for major unmet medical needs. Islet Cell Transplantation The company is exploring technology options and collaborations for developing the use of porcine pancreatic islet cells from its GalT-KO miniature swine to treat brittle type 1 diabetics and diabetic patients with renal failure. Competition The company identifies competition from Revivicor and the Mayo Clinic group. History Xeno Transplants Corp. was founded in 2006.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
XENO:US $0.00 USD 0.00

XENO Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for XENO.
View Industry Companies

Industry Analysis


Industry Average

Valuation XENO Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book 4.2x
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact XENO TRANSPLANTS CORP, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at